# US 2026/0063618 A1 · Method of characterising a target polypeptide using a nanopore

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0063618 A1
- Document ID: US20260063618A1
- Status: Published application
- Kind: A1
- Application number: 19/314,260
- Filed: 2025-08-29
- Published: 2026-03-05
- Earliest claimed: 2019-12-02
- Assignees: Oxford Nanopore Technolgies PLC
- Applicants: Oxford Nanopore Technologies PLC
- Inventors: Andrew John Heron; James Edward Graham; Melania Slawa Strycharska
- Web page: https://patentgrep.com/patent/US20260063618A1

## CPC

- G01N 33/48721: {Investigating individual macromolecules, e.g. by translocation through nanopores (Coulter counters in general G01N15/12; fabrication methods for nanoscale apertures B81B1/00; sequencing of nucleic acids C12Q1/68)}
- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- G01N 33/6818: {Sequencing of polypeptides}
- C12N 2310/3517: Marker; Tag
- G01N 2458/00: Labels used in chemical analysis of biological material
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Provided herein are methods of characterising a target polypeptide as it moves with respect to a nanopore. Also provided are related kits, systems and apparatuses for carrying out such methods.

## Claims

### Claim at position 1

1-31. (canceled)

### Claim 32

A method of controlling movement of a target polypeptide through a transmembrane protein pore, the method comprising:
(i) conjugating the target polypeptide to a polynucleotide to form a polynucleotide-polypeptide conjugate;
(ii) contacting the polynucleotide-polypeptide conjugate with a polynucleotide-handling protein;
(iii) controlling the movement of the polynucleotide through the transmembrane protein pore using the polynucleotide-handling protein, thereby controlling the movement of the target polypeptide through the transmembrane protein pore; and
(iv) taking one or more electrical measurements as the polynucleotide-polypeptide conjugate moves with respect to the transmembrane protein pore.
wherein the polynucleotide-polypeptide conjugate comprises a leader that facilitates threading of the polynucleotide-polypeptide conjugate through the transmembrane protein pore, and
wherein the transmembrane protein pore comprises a cis side and a trans side.

### Claim 33 (depends on 32)

The method of claim 32, wherein:
(a) the polynucleotide-handling protein is located on the cis side of the transmembrane protein pore and the polynucleotide-handling protein controls the movement of the polynucleotide-polypeptide conjugate from the cis side of the transmembrane protein pore to the trans side of the transmembrane protein pore; or
(b) the polynucleotide-handling protein is located on the trans side of the transmembrane protein pore and the polynucleotide-handling protein controls the movement of the polynucleotide-polypeptide conjugate from the trans side of the transmembrane protein pore to the cis side of the transmembrane protein pore.

### Claim 34 (depends on 32)

The method of claim 32, wherein:
(a) the polynucleotide-handling protein is located on the cis side of the transmembrane protein pore and the polynucleotide-handling protein controls the movement of the polynucleotide-polypeptide conjugate from the trans side of the transmembrane protein pore to the cis side of the transmembrane protein pore; or
(b) the polynucleotide-handling protein is located on the trans side of the transmembrane protein pore and the polynucleotide-handling protein controls the movement of the polynucleotide-polypeptide conjugate from the cis side of the transmembrane protein pore to the trans side of the transmembrane protein pore.

### Claim 35 (depends on 32)

The method of claim 32, wherein the target polypeptide of the polynucleotide-polypeptide conjugate comprises a plurality of polypeptide sections and/or the polynucleotide of the polynucleotide-polypeptide conjugate comprises a plurality of polynucleotide sections.

### Claim 36 (depends on 32)

The method of claim 32, wherein the polynucleotide-polypeptide conjugate comprises one or more structures of the form L-{P-N}-Pm, wherein:
L is a leader;
P is the target polypeptide;
N comprises the polynucleotide; and
m is 0 or 1; and
wherein the method comprises threading the leader (L) through the transmembrane protein pore.

### Claim 37 (depends on 32)

The method of claim 32, wherein the polynucleotide-polypeptide conjugate comprises one or more structures of the form L-{P-N}-Pm,
wherein:
L is the leader;
P is the target polypeptide;
N comprises the polynucleotide; and
m is 0 or 1; and
wherein the method comprises threading the leader (L) through the transmembrane protein pore such that:
(a) the polynucleotide-handling protein is located on the cis side of the transmembrane protein pore and the polynucleotide-handling protein controls the movement of the polynucleotide (N) from the cis side of the transmembrane protein pore to the trans side of the transmembrane protein pore, thereby controlling the movement of the target polypeptide (P) through the transmembrane protein pore; or
(b) the polynucleotide-handling protein is located on the trans side of the transmembrane protein pore and the polynucleotide-handling protein controls the movement of the polynucleotide (N) from the trans side of the transmembrane protein pore to the cis side of the transmembrane protein pore, thereby controlling the movement of the target polypeptide (P) through the transmembrane protein pore.

### Claim 38 (depends on 32)

The method of claim 32, wherein the polynucleotide-polypeptide conjugate comprises one or more structures of the form L-P1-N-{P-N}n-Pm, wherein:
L is the leader;
each P is independently the target polypeptide, which may be the same or different;
each N is independently the polynucleotide, which may be the same or different;
n is a positive integer; and
m is 0 or 1; and
wherein the method comprises threading the leader (L) through the transmembrane protein pore, such that:
(a) the polynucleotide-handling protein is located on the cis side of the transmembrane protein pore and the polynucleotide-handling protein controls the movement of each polynucleotide (N) from the cis side of the transmembrane protein pore to the trans side of the transmembrane protein pore, thereby controlling the movement of each polypeptide (P) sequentially through the transmembrane protein pore; or
(b) the polynucleotide-handling protein is located on the trans side of the transmembrane protein pore and the polynucleotide-handling protein controls the movement of each polynucleotide (N) from the trans side of the transmembrane protein pore to the cis side of the transmembrane protein pore, thereby controlling the movement of each polypeptide (P) sequentially through the transmembrane protein pore.

### Claim 39 (depends on 32)

The method of claim 32, wherein the polynucleotide-polypeptide conjugate comprises one or more structures of the form L-{P-N}-Pm, wherein:
L is the leader;
P is the target polypeptide;
N comprises the polynucleotide; and
m is 0 or 1; and
wherein the method comprises threading the leader (L) through the transmembrane protein pore, such that:
(a) the polynucleotide-handling protein is located on the cis side of the transmembrane protein pore and the polynucleotide-handling protein controls the movement of the polynucleotide (N) from the trans side of the transmembrane protein pore to the cis side of the transmembrane protein pore, thereby controlling the movement of the target polypeptide (P) through the transmembrane protein pore; or
(b) the polynucleotide-handling protein is located on the trans side of the transmembrane protein pore and the polynucleotide-handling protein controls the movement of the polynucleotide (N) from the cis side of the transmembrane protein pore to the trans side of the transmembrane protein pore, thereby controlling the movement of the target polypeptide (P) through the transmembrane protein pore.

### Claim 40 (depends on 32)

The method of claim 32, wherein the polynucleotide-handling protein is a helicase.

### Claim 41 (depends on 32)

The method of claim 32, wherein the target polypeptide has a length of from 2 to about 50 peptide units.

### Claim 42 (depends on 32)

The method of claim 32, wherein the polynucleotide has a length of from about 10 to about 1000 nucleotides.

### Claim 43 (depends on 32)

The method of claim 32, wherein the leader comprises a polynucleotide or a charged polymer.

### Claim 44 (depends on 32)

The method of claim 32, wherein the leader is a polynucleotide.

### Claim 45 (depends on 32)

The method of claim 32, wherein the leader is a polysaccharide.

### Claim 46 (depends on 45)

The method of claim 45, wherein the leader is 10 to 150 monomer units in length.

### Claim 47 (depends on 32)

The method of claim 32, wherein the transmembrane protein pore comprises a constriction region.

### Claim 48 (depends on 32)

The method of claim 32, wherein the transmembrane protein pore is derived from Mycobacterium smegmatis porin (Msp), α-hemolysin, CsgG, Cytolysin A (ClyA), Sp1, or haemolytic protein fragaceatoxin C (FraC).

### Claim 49 (depends on 32)

The method of claim 32, wherein the transmembrane protein pore is derived from Msp or from CsgG.

### Claim 50 (depends on 32)

The method of claim 32, wherein the transmembrane protein pore is a MspA pore.

### Claim 51 (depends on 32)

The method of claim 32, wherein taking the one or more electrical measurements comprises measuring an ion current flow through the transmembrane protein pore.
